FDA Hydroquinone Proposal Should Prompt Industry Studies – Dermatologists
This article was originally published in The Tan Sheet
Executive Summary
Dermatologists concerned about losing over-the-counter access to skin bleaching products formulated with hydroquinone - as proposed by FDA - are counting on industry to submit compelling safety data
You may also be interested in...
Proposed Hydroquinone Ban Criticized In Literature Review
Disrupting the availability of hydroquinone skin-lightening products would represent an "overreaction" by FDA, according to a literature review published in the November issue of the Journal of the American Academy of Dermatology
Proposed Hydroquinone Ban Criticized In Literature Review
Disrupting the availability of hydroquinone skin-lightening products would represent an "overreaction" by FDA, according to a literature review published in the November issue of the Journal of the American Academy of Dermatology
FDA Pushes For Prescription-Only Sale Of Skin-Bleaching Products
FDA is proposing a rule that classifies all over-the-counter skin-bleaching products as drugs requiring an approved new drug application, the agency announced in a notice of proposed rulemaking published in an Aug. 29 Federal Register notice